Western Blot: Arginase 1/ARG1/liver Arginase Antibody [NB100-59740] - Staining of Mouse Liver (A) and Rat Liver (B) lysates (35ug protein in RIPA buffer). Detected by chemiluminescence.
Simple Western: Arginase 1/ARG1/liver Arginase Antibody [NB100-59740] - Simple Western lane view shows a specific band for ARG1 in mouse Liver lysate using ARG1 antibody (NB100-59740) at 5 ug/ml. This experiment was ...read more
WB: Approx. 37 kDa band observed in mouse and rat liver lysates (calculated MW of 34.8 kDa band according to mouse NP_031508.1). IHC-F usage is reported in scientific literature (PMID: 24089194). Use in ICC/IF reported in scientific literature (PMID 28246332). Use in FC reported in (PMID: 24089194). Use in IHC reported in scientific literature (PMID: 23207546).
Theoretical MW
37 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Human reactivity reported in scientific literature (PMID: 28246332).
Packaging, Storage & Formulations
Storage
Store at -20C. Avoid freeze-thaw cycles.
Buffer
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Purity
Immunogen affinity purified
Alternate Names for Arginase 1/ARG1/liver Arginase Antibody
AI
ARG1
Arginase 1
arginase, liver
Arginase-1
EC 3.5.3.1
Liver Arginase
Liver-type arginase
PGIF
Type I Arginase
Background
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Reviews for Arginase 1/ARG1/liver Arginase Antibody (NB100-59740) (0)
There are no reviews for Arginase 1/ARG1/liver Arginase Antibody (NB100-59740).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Bioinformatics Tool for Arginase 1/ARG1/liver Arginase Antibody (NB100-59740)
Discover related pathways, diseases and genes to Arginase 1/ARG1/liver Arginase Antibody (NB100-59740). Need help?
Read the Bioinformatics Tool Guide for instructions on using this tool.
Diseases for Arginase 1/ARG1/liver Arginase Antibody (NB100-59740)
Discover more about diseases related to Arginase 1/ARG1/liver Arginase Antibody (NB100-59740).
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Arginase 1/ARG1/liver Arginase Antibody and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.